| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/22/2023 | 257.4% | Cantor Fitzgerald | → $1 | Reiterates | Overweight → Overweight |
| 08/11/2023 | 614.8% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 05/12/2023 | 614.8% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 03/06/2023 | 614.8% | HC Wainwright & Co. | $3 → $2 | Maintains | Buy |
| 02/22/2023 | 972.19% | HC Wainwright & Co. | → $3 | Reiterates | → Buy |
| 01/10/2023 | 972.19% | HC Wainwright & Co. | → $3 | Reiterates | → Buy |
| 09/08/2022 | 436.1% | Cantor Fitzgerald | → $1.5 | Initiates Coverage On | → Overweight |
| 08/10/2022 | 972.19% | HC Wainwright & Co. | $4 → $3 | Maintains | Buy |
| 05/26/2021 | 1329.59% | HC Wainwright & Co. | → $4 | Initiates Coverage On | → Buy |
What is the target price for Asensus Surgical (ASXC)?
The latest price target for Asensus Surgical (AMEX: ASXC) was reported by Cantor Fitzgerald on August 22, 2023. The analyst firm set a price target for $1.00 expecting ASXC to rise to within 12 months (a possible 257.40% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Asensus Surgical (ASXC)?
The latest analyst rating for Asensus Surgical (AMEX: ASXC) was provided by Cantor Fitzgerald, and Asensus Surgical reiterated their overweight rating.
When is the next analyst rating going to be posted or updated for Asensus Surgical (ASXC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Asensus Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Asensus Surgical was filed on August 22, 2023 so you should expect the next rating to be made available sometime around August 22, 2024.
Is the Analyst Rating Asensus Surgical (ASXC) correct?
While ratings are subjective and will change, the latest Asensus Surgical (ASXC) rating was a reiterated with a price target of $0.00 to $1.00. The current price Asensus Surgical (ASXC) is trading at is $0.28, which is within the analyst's predicted range.